Rockwell Medical (RMTI) to Acquire Vantive HD Business for $125M

What happened

Rockwell Medical agreed to acquire Vantive’s hemodialysis business and Medolla campus for $125M, subject to customary adjustments, with up to $45M in additional payments tied to conditions. The proposed deal awaits approvals, is expected to close in mid-2027, and Rockwell withdrew its 2026 guidance.

Proposed

Global impact / market context

If completed, the acquisition would broaden Rockwell Medical’s business and could bring estimated annual combined revenue of $400M–$450M. It would also be financed with loans and a note, adding repayment or conversion obligations, while withdrawn guidance leaves investors with less near-term visibility.

Analyst inference

The transaction is not final: approvals and closing conditions remain outstanding, and completion is expected only in mid-2027. The revenue estimate depends on current assumptions and successful integration, so investors cannot yet treat the projected scale as realized sales or earnings.

Analyst inference

What to watch

1. Whether required approvals and other closing conditions are satisfied, since the acquisition cannot proceed to its expected mid-2027 closing without them. Confirmed
2. How the $100M in loans and $25M note are finalized, including any contingent payments that could raise the transaction’s total cost by up to $45M. Confirmed
3. Any updated outlook for sales, gross margin, adjusted EBITDA and operating cash flow, since Rockwell withdrew its 2026 guidance and near-term visibility is reduced. Analyst inference

Evidence

• Original source link unavailable